Delivery Order SPE2DB24D2101-SPE2DB25FKKRH
Award Date
5/19/25
Potential Completion Date
6/10/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a medication used to treat non-small cell lung cancer. The contract has a ceiling value of $10,662.57 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a medication used to treat non-small cell lung cancer. The award has a ceiling value of $21,325.14 and a period of performance through April 28, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,662.57, is for the delivery of Tagrisso 80 mg tablets, a medication used in cancer treatment. The contract has a firm fixed price and an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor in the United States. The contract is for the supply of the prescription drug Tagrisso 80 mg tablets, which are used to treat a specific type of non-small cell lung cancer. The contract has a ceiling value of $10,538.79 and runs through September 24, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Tagrisso 80 mg tablets. The contract has a ceiling value of $74,637.99 and a completion date of June 11, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the cancer drug TAGRISSO 40 MG TABLET 30S. The contract has a ceiling value of $21,016.64 and a period of performance through October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of Tagrisso 80 mg tablets, a specialty pharmaceutical product. The award has a ceiling value of $21,077.60 and a completion date of April 12, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp also holds an...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $20,347.75 and an ultimate completion date of November 7, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $31,987.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a medication used to treat certain types of lung cancer. The contract is a firm fixed-price delivery order with a performance period extending through May 28, 2025. It is not designated as a set-aside contract, indicating open...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Tagrisso 40 mg tablet 30s. The contract has a ceiling value of $10,508.31 and a period of performance through April 18, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which serves as the prime...